Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -4.89% is 256% below its 5-year average of -1.37%, near the low end of its 5-year range (-4.89%–0.94%).
1024.14% below its 12-month average of -0.43%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -3.95%.
RETURN ON ASSETS (ROA)
-4.89%
RETURN ON ASSETS (ROA) AVG TTM
-0.43%
RETURN ON ASSETS (ROA) AVG 3Y
-0.87%
RETURN ON ASSETS (ROA) AVG 5Y
-1.37%
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
-1024.14%
CURRENT VS 3Y AVG
-463.69%
CURRENT VS 5Y AVG
-256.07%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-28.05%
median of 558 covered companies
CURRENT VS SECTOR MEDIAN
+82.56%
vs the sector median at left
Certara, Inc.
Market Cap
$1.55B
Return on Assets (ROA)
-4.89%
TTM Avg
-0.43%
3Y Avg
-0.87%
5Y Avg
-1.37%
Market Cap
$1.53B
Return on Assets (ROA)
20.98%
TTM Avg
9.19%
3Y Avg
12.55%
5Y Avg
16.89%
Market Cap
$1.50B
Return on Assets (ROA)
10.96%
TTM Avg
-5.00%
3Y Avg
-12.25%
5Y Avg
-27.07%
Market Cap
$1.50B
Return on Assets (ROA)
-16.72%
TTM Avg
-18.71%
3Y Avg
-15.50%
5Y Avg
-12.14%
Market Cap
$1.49B
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.46B
Return on Assets (ROA)
-25.13%
TTM Avg
-5.66%
3Y Avg
-57.10%
5Y Avg
-57.10%
Market Cap
$1.47B
Return on Assets (ROA)
14.98%
TTM Avg
6.07%
3Y Avg
5.42%
5Y Avg
6.72%
Market Cap
$1.65B
Return on Assets (ROA)
7.08%
TTM Avg
2.00%
3Y Avg
-0.05%
5Y Avg
-1.77%
Market Cap
$1.66B
Return on Assets (ROA)
-13.91%
TTM Avg
-19.51%
3Y Avg
-22.81%
5Y Avg
-24.34%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Certara, Inc. (CERT) | $1.55B | -4.89% | -0.43% | -0.87% | -1.37% |
| Innoviva, Inc. (INVA)vs › | $1.53B | 20.98% | 9.19% | 12.55% | 16.89% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 10.96% | -5.00% | -12.25% | -27.07% |
| GH Research PLC (GHRS)vs › | $1.50B | -16.72% | -18.71% | -15.50% | -12.14% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.49B | N/A | N/A | N/A | N/A |
| Maze Therapeutics, Inc. (MAZE)vs › | $1.46B | -25.13% | -5.66% | -57.10% | -57.10% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.47B | 14.98% | 6.07% | 5.42% | 6.72% |
| ANI Pharmaceuticals, Inc. (ANIP)vs › | $1.65B | 7.08% | 2.00% | -0.05% | -1.77% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.66B | -13.91% | -19.51% | -22.81% | -24.34% |
| AnaptysBio, Inc. (ANAB)vs › | $1.44B | 61.75% | -16.82% | -22.73% | -17.45% |
ROA
-4.9%
ROE
-7.1%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -0.10% |
| 2024-12-31 | -0.77% |
| 2023-12-31 | -3.54% |
| 2022-12-31 | 0.94% |
| 2021-12-31 | -0.88% |
| 2020-12-31 | -3.89% |
| 2019-12-31 | -0.86% |
| 2018-12-31 | -3.16% |
